AI assistant
LEVI STRAUSS & CO — Director's Dealing 2020
Jan 14, 2020
30653_dirs_2020-01-14_64721344-b58b-4fec-8690-f21a3d2d5f9d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEVI STRAUSS & CO (LEVI)
CIK: 0000094845
Period of Report: 2020-01-10
Reporting Person: Ellison Seth M. (EVP & President, Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-13 | Class A Common Stock | C | 10578 | $0.00 | Acquired | 87694 | Direct |
| 2020-01-13 | Class A Common Stock | S | 10578 | $18.80 | Disposed | 77116 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-01-10 | Stock Appreciation Rights | $6.10 | M | 25000 | Disposed | 2023-02-09 | Class B Common Stock (25000) | Direct |
| 2020-01-10 | Class B Common Stock | $ | M | 25000 | Acquired | Class A Common Stock (25000) | Direct | |
| 2020-01-10 | Class B Common Stock | $ | D | 14422 | Disposed | Class A Common Stock (14422) | Direct | |
| 2020-01-13 | Class B Common Stock | $ | C | 10578 | Disposed | Class A Common Stock (10578) | Direct |
Footnotes
F1: Transaction pursuant to a previously established Rule 10b5-1 Plan.
F2: Represents the conversion of Class B Common Stock into Class A Common Stock held of record by the Reporting Person.
F3: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $18.58 to $18.91. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4: Of these SARs: (i) 229,830 are performance stock appreciation rights (PSARs) that vested on January 30, 2019 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors, and are immediately exercisable; and (ii) 67,390 are time-based SARs from an original grant of 275,800 SARs, of which 208,410 have been exercised, that vested as to 25% of the SARs on February 9, 2017, with the remainder vesting in 36 equal monthly installments thereafter.
F5: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.